Legal & Litigation Risk · SECTION 6

Section 6 of 12

Tornetta procedural arc — April 2018 to December 2025

Long-form source as of 2026-08-10

Seven years. Two captions. Two trial-court judges. One Supreme Court reversal that didn’t reach liability. The Tornetta arc is the catalyst case for the post-2024 Texas reincorporation cohort and the doctrinal arc most likely to shape the next decade of officer-compensation litigation. The procedural complexity matters: the 2018 MTD denial (Slights, V.C.) sits under one docket number (2018-0408-JRS), the 2024 post-trial rescission (McCormick, C.) under another (2018-0408-KSJM), and the December 2025 Delaware Supreme Court reversal travels under the consolidated caption In re Tesla, Inc. Derivative Litigation. Counsel reading the case file must hold all three lines in view.

Figure 6

Tornetta procedural arc — April 2018 to December 2025.

Seven years. Two captions. Two trial-court judges. One Supreme Court reversal that didn’t reach liability.

APR 2018 Trigger 2018 CEO comp grant Tesla board approves 56M-option performance plan for Elon Musk JUN 2018 Pleadings Derivative complaint Tornetta files C.A. 2018-0408-JRS (Slights, V.C.) SEP 2019 Liability theory Tornetta v. Musk 250 A.3d 793 (Del. Ch.) MTD denied; entire- fairness framework adopted on controller- transaction theory JAN 30, 2024 Rescission Tornetta v. Musk 310 A.3d 430 (Del. Ch.) Chancellor McCormick rescinds grant post-trial on entire-fairness grounds; C.A. 2018-0408-KSJM JUN 13, 2024 Reincorporation Tesla → Texas Tesla redomesticates to Texas; same-day vote ratifies 2018 award 8-K accession 0001104659-24-071439 DEC 19, 2025 Appellate disposition In re Tesla, Inc. Deriv. Litig. 2025 WL 3689114 Del. Supreme Court, en banc per curiam: rescission reversed $1 nominal damages fee: $345M → 4× lodestar Why the appellate disposition matters less than the headlines Docket reassigned from V.C. Slights (2018-0408-JRS) to Chancellor McCormick (2018-0408-KSJM) upon her elevation. The per curiam opinion noted that “the Justices have varying views on the liability determination” and resolved on remedy grounds alone — Chancery’s entire-fairness liability holdings therefore remain as trial-court decisions without Supreme Court endorsement. Counsel advising controlled Texas-domiciled issuers should treat neither the Chancery liability holding nor the Supreme Court reversal as appellate-endorsed precedent. Sources: Tornetta v. Musk, 250 A.3d 793 (Del. Ch. 2019) (Slights, V.C.); Tornetta v. Musk, 310 A.3d 430 (Del. Ch. 2024) (McCormick, C.) (post-trial rescission); Tornetta v. Musk, 326 A.3d 1203 (Del. Ch. 2024) (McCormick, C.) ($345M fee award); In re Tesla, Inc. Deriv. Litig., 2025 WL 3689114 (Del. Dec. 19, 2025) (en banc, per curiam); Tesla 8-K accession 0001104659-24-071439. Tesla Form 8-K filed June 14, 2024 (period of report: June 13, 2024 stockholder vote on Proposal 3).

Sources: Tornetta v. Musk, 250 A.3d 793 (Del. Ch. 2019) (Slights, V.C.); Tornetta v. Musk, 310 A.3d 430 (Del. Ch. 2024) (McCormick, C.) (post-trial rescission); Tornetta v. Musk, 326 A.3d 1203 (Del. Ch. 2024) (McCormick, C.) ($345M fee award); In re Tesla, Inc. Deriv. Litig., 2025 WL 3689114 (Del. Dec. 19, 2025) (en banc, per curiam); Tesla’s redomestication is documented in Tesla Form 8-K (accession 0001104659-24-071439) and Q2 2024 10-Q.

Doctrinal posture for Texas-domiciled controlled issuers

Counsel advising controlled Texas-domiciled issuers should not treat the December 19, 2025 Delaware Supreme Court reversal as a wholesale repudiation of the Chancery liability framework. The reversal is on remedy grounds and the per curiam explicitly notes “varying views” among the Justices on liability. Equally, counsel should not treat the Chancery liability holding as appellate-endorsed precedent — it stands as a trial-court entire-fairness analysis that the Supreme Court reviewed but did not reach. The doctrinally open question is whether either holding carries weight under codified Texas BJR (TBOC § 21.419) on the same facts in a Texas Business Court. As of the date of this page, no Texas appellate decision has resolved the question.

← All Legal & Litigation Risk sections